Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001234815 | SCV001407475 | uncertain significance | not provided | 2022-10-18 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the TUBGCP6 gene (p.Pro1759Alafs*68). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 61 amino acid(s) of the TUBGCP6 protein and extend the protein by 6 additional amino acid residues. This variant is present in population databases (rs757636489, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TUBGCP6-related conditions. ClinVar contains an entry for this variant (Variation ID: 961164). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001234815 | SCV001823509 | uncertain significance | not provided | 2020-11-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation as the last 61 amino acids are replaced with 67 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002563817 | SCV003687666 | uncertain significance | Inborn genetic diseases | 2022-06-28 | criteria provided, single submitter | clinical testing | Not expected to trigger nonsense-mediated mRNA decay Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Institute of Medical Genetics and Genomics, |
RCV003473806 | SCV004190198 | likely pathogenic | Microcephaly and chorioretinopathy 1 | 2023-12-25 | criteria provided, single submitter | clinical testing | Loss of functions variants are known to cause disease as the disease mechanism [PVS1]. This variant is present in population database with an allele frequency of 0.009% (gnomAD). This heterozygous 11 base deletion found in a compound heterozygous state along with a long ~405 base deletion in 2 similarly afftected individuals of the same family. |